Adebrelimab Combined With Chemotherapy for the Esophageal Squamous Cell Carcinoma

NCT07430579 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Pathological Complete Remission
Objective Response Rate
Immune-related Adverse Events
Quality of Life

Interventions

PROCEDURE: adebrelimab combined with chemotherapy

Sponsor

The Second Hospital of Shandong University